Abstract:Objectives: To determine whether leukocyte-poor platelet-rich plasma (Lp-PRP) reduced retear rates, reduced fatty infiltration, and improved functional outcomes in patients with degenerative moderate-to-large rotator cuff tears. Methods: This was a randomized controlled study at a single center. A consecutive series of 104 patients with moderateto-large rotator cuff tears was enrolled and randomly allocated to a control group (double-row suture-bridge arthroscopic rotator cuff repair alone, n = 52) and a study group (double-row suture-bridge repair followed by 3 Lp-PRP injections at the tendon repair site during surgery, at days 7 and 14 after surgery, n = 52). All patients were followed up for 27.2 months (range 24-36 months), with University of California at Los Angeles (UCLA) shoulder rating scale, the Constant score, and a visual analog scale (VAS) evaluated respectively. The integrity and fatty infiltration of repaired tissue were assessed by magnetic resonance imaging using the Sugaya classification and Goutallier grade classification at 24 months after surgery. Statistical analysis was performed based on the t test, chi(2) test, and the Kendall tau-b correlation coefficient. Results: Four patients refused follow-up, and 11 patients had incomplete data. Eventually, a total of 89 patients were available for 24 months follow-up. The mean UCLA score increased from 14.80 +/- 2.53 to 29.37 +/- 2.06 in control group and from 13.74 +/- 3.30 to 30.14 +/- 2.32 in study group (P =.103). The mean Constant score increased from 46.56 +/- 5.90 to 86.83 +/- 4.94 in control group and from 44.37 +/- 7.92 to 88.80 +/- 4.92 in study group (P =.063). The VAS score decreased from 3.22 +/- 1.24 to 0.97 +/- 1.12 in control group and in 3.49 +/- 1.52 to 1.16 +/- 0.99 in study group (P =.41). All differences in UCLA score, Constant score, and VAS between pre- and postoperation achieved minimal clinically important differences proposed for arthroscopic rotator cuff repair. Of the 89 patients, 76 had magnetic resonance imaging performed at 24 months after surgery. The retear rate was 17.6% in study group, which was lower than that in control group (38.1%, P = .049). In addition, the Goutallier grade was found to be significant difference between groups postoperatively (Kendall tau-b e0.24, P = .03) but no significant difference preoperatively (Kendall tau-b e0.18, P = .11). There were no complications in the patients. Conclusions: Our procedures involving repeated injections of Lp-PRP during surgery and at days 7 and 14, as described in this study, have positive effects on reducing retear rate and promoting Goutallier grade in patients following arthroscopic rotator cuff repair and could also provide substantial clinical outcomes that reach the minimal clinically important difference for surgical treatment. However, given the numbers available for analysis, it did not promote better clinical results when compared with the control group.

Intratendon Delivery of Leukocyte-Poor Platelet-Rich Plasma Improves Healing Compared With Leukocyte-Rich Platelet-Rich Plasma in a Rabbit Achilles Tendinopathy Model:

Early-Stage Primary Anti-inflammatory Therapy Enhances the Regenerative Efficacy of Platelet-Rich Plasma in a Rabbit Achilles Tendinopathy Model.

Injection of Leukocyte-Poor Platelet-Rich Plasma for Moderate-to-Large Rotator Cuff Tears Does Not Improve Clinical Outcomes but Reduces Retear Rates and Fatty Infiltration: A Prospective, Single-Blinded Randomized Study

Tendon derived stem cells promote platelet-rich plasma healing in collagenase-induced rat achilles tendinopathy.

Effects of leukocyte-rich platelet-rich plasma and leukocyte-poor platelet-rich plasma on the healing of bone-tendon interface of rotator cuff in a mice model

[Effect of Platelet-Rich Plasma on Tendon Healing].

[Progress on Treatment of Tendinopathy with Platelet-Enriched Plasma].

Platelet-Rich Plasma for Patellar Tendinopathy: A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline

Platelet-rich Plasma in the Pathologic Processes of Tendinopathy: a Review of Basic Science Studies

Characteristics of L-PRP preparations for treating Achilles tendon rupture within the PATH-2 study

Does platelet-rich plasma deserve a role in the treatment of tendinopathy?

Platelet HMGB1 in Platelet-Rich Plasma (PRP) promotes tendon wound healing

Efficacy of Platelet-Rich Plasma Versus Placebo in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Trials

The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-analysis With Bias Assessment.

Comparative Evaluation Of Leukocyte- And Platelet-Rich Plasma And Pure Platelet-Rich Plasma For Cartilage Regeneration In A Cartilage Defects Model In Rabbits

Effect of Platelet-Rich Plasma Injection on the Treatment of Achilles Tendinopathy: A Systematic Review and Meta-analysis

Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis.

Effects of Leukocyte-rich platelet-rich plasma and Leukocyte-poor platelet-rich plasma on cartilage in a rabbit osteoarthritis model

Platelet-rich plasma (PRP) accelerates murine patellar tendon healing through enhancement of angiogenesis and collagen synthesis

PRP Treatment Efficacy for Tendinopathy: A Review of Basic Science Studies

A Prospective Randomized Clinical Trial of Platelet-Rich Plasma Used in Surgery for De Quervain Tendinopathy